共 50 条
- [38] Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection Leukemia, 2020, 34 : 3055 - 3059
- [40] HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure VIRUSES-BASEL, 2022, 14 (04):